Vivos Therapeutics And SoundHealth Collaborate To Advance Access To SoundHealth's Consumer-Focused Airway And Sleep Health Technologies

Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market

LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders, and SoundHealth, a Silicon Valley based health technology company focused on AI enabled, clinically proven allergy and sleep therapeutics, today announced a collaboration to advance public awareness and access to SoundHealth's consumer-focused airway and sleep health technologies.

The collaboration leverages Vivos' extensive national network of over 2,000 Vivos-trained dentists and sleep healthcare providers, along with affiliated sleep testing centers in select markets, to distribute SoundHealth's Sonu® platform, including the FDA-cleared Sonu® Band and the newly released Spatial Sleep™ band. Both devices use personalized vibro-acoustic neuromodulation to harness the body's natural mechanisms to enable clear nasal breathing and promote deep, restful sleep.